Major histocompatibility complex and human papillomavirus type 16 E7 expression in high-grade vulvar lesions.
To determine whether expression of the human papillomavirus (HPV) type 16 E7 open reading frame influences expression of major histocompatibility complex (MHC) antigens on the surface of squamous epithelial cells, serial frozen sections from seven HPV type 16-positive, high-grade vulvar intraepithelial neoplasia (VIN 2-3) lesions were tested for viral transcription by RNA-RNA in situ hybridization, for MHC expression by immunohistochemical staining with antibodies to MHC class I and II molecules, and for keratinocyte differentiation by immunohistochemical staining with anti-filaggrin and cytokeratin 10 antibodies. Despite the histologic appearance of high-grade VIN lesions, expression patterns of cytokeratin 10 and filaggrin suggested a certain degree of keratinocyte differentiation in all specimens. These differentiation markers were especially prominent in parakeratotic and hyperkeratotic superficial areas, which did not express MHC antigens or contain E7 mRNA. Expression of MHC class I molecules within dysplastic tissues was greater than within HPV type 16-negative, normal vulvar epithelium from the same patients. In five of the VIN 2-3 specimens anti-MHC class I antibodies reacted more strongly with cells of the basal and suprabasal layers than with cells of the epithelial surface. In one lesion basal cells stained less intensively than surface cells, whereas in another specimen all epithelial layers were equally MHC class I positive. Staining with anti-MHC class II antibodies was generally restricted to isolated foci, representing invading lymphocytes, tissue macrophages, and Langerhans cells. In two lesions, however, there was heterogeneous keratinocyte expression of MHC class II proteins, perhaps due to inflammation. Major histocompatibility complex antigen detection was independent of the presence or distribution pattern of E7-specific transcripts. Hence, a correlation between MHC and E7 expression appears unlikely in warty VIN lesions.
Jochmus
I
I
Department of Pathology, Georgetown University School of Medicine, Washington, DC.
Dürst
M
M
Reid
R
R
Altmann
A
A
Bijward
K E
KE
Gissmann
L
L
Jenson
A B
AB
D000328:Adult; D000911:Antibodies, Monoclonal; D004279:DNA, Viral / Q000032:analysis*; D005260:Female; D000091344:Filaggrin Proteins; D006680:HLA Antigens / Q000032:analysis; D006801:Humans; D017403:In Situ Hybridization; D015603:Keratinocytes / Q000276:immunology; D008285:Major Histocompatibility Complex; D008875:Middle Aged; D009856:Oncogene Proteins, Viral / Q000235:genetics*; D027383:Papillomaviridae / Q000235:genetics*; D050725:Papillomavirus E7 Proteins; D014846:Vulvar Neoplasms / Q000276:immunology* / Q000382:microbiology* / Q000473:pathology
D000911:Antibodies, Monoclonal; D004279:DNA, Viral; C000717249:FLG protein, human; D000091344:Filaggrin Proteins; D006680:HLA Antigens; D009856:Oncogene Proteins, Viral; D050725:Papillomavirus E7 Proteins; C059731:oncogene protein E7, Human papillomavirus type 16